Tango Therapeutics (TNGX) Net Income (QoQ) (2020 - 2026)
Tango Therapeutics (TNGX) Net Income (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,930.48 Bn | 1,930.42 Bn | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - |
| 4 | BeOne Medicines | 468.55 Bn | 463.76 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.04 Bn | 115.79 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.31 Bn | 61.56 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.40 Bn | 63.40 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | Tango Therapeutics | 3.85 Bn | 3.69 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.46% |
| Dec 31, 2025 | -343.94% |
| Sep 30, 2025 | 140.88% |
| Jun 30, 2025 | 2.57% |
| Mar 31, 2025 | -5.86% |
| Dec 31, 2024 | -29.15% |
| Sep 30, 2024 | -14.15% |
| Jun 30, 2024 | 32.61% |
| Mar 31, 2024 | -23.38% |
| Dec 31, 2023 | -38.03% |
| Sep 30, 2023 | -7.31% |
| Jun 30, 2023 | 25.93% |
| Mar 31, 2023 | 3.77% |
| Dec 31, 2022 | -0.19% |
| Sep 30, 2022 | -16.86% |
| Jun 30, 2022 | 1.39% |
| Mar 31, 2022 | -14.34% |
| Dec 31, 2021 | -12.54% |
| Sep 30, 2021 | -336.01% |
| Jun 30, 2021 | 62.89% |